Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 179,421 | 436,189 | 246,351 | 129,608 | 79,055 |
Marketable Securities | 323,795 | 109,761 | 167,804 | 216,196 | 153,619 |
Receivables | 136,936 | 131,816 | 200,362 | 105,900 | 83,994 |
Inventories | 79,038 | 61,335 | 67,297 | 86,451 | 68,846 |
TOTAL | $940,515 | $972,520 | $852,670 | $583,906 | $427,533 |
Non-Current Assets | |||||
PPE Net | 36,407 | 35,020 | 34,251 | 32,547 | 30,696 |
Intangibles | 2,082 | 2,125 | 2,171 | 2,225 | 2,197 |
Other Non-Current Assets | 29,971 | 29,581 | 30,619 | 29,231 | 29,693 |
TOTAL | $68,460 | $66,726 | $67,041 | $64,003 | $62,586 |
Total Assets | $1,008,975 | $1,039,246 | $919,711 | $647,909 | $490,119 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 20,194 | 2,600 | 3,596 | 12,079 | 3,154 |
Accrued Expenses | 22,467 | 54,484 | 91,845 | 29,878 | 18,973 |
Other current liabilities | 110,339 | 149,454 | 74,906 | 33,128 | 35,093 |
TOTAL | $466,203 | $556,402 | $528,935 | $204,642 | $109,422 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | N/A | N/A | 179,889 |
Deferred Revenues | 313,203 | 349,864 | 358,588 | 129,557 | 52,202 |
aiOther Non-Current Liabilities | 255,288 | 260,470 | 255,231 | 252,937 | 36,696 |
TOTAL | $255,288 | $260,470 | $323,200 | $359,887 | $280,935 |
Total Liabilities | $721,491 | $816,872 | $852,135 | $564,529 | $390,357 |
Shareholders' Equity | |||||
Shares Outstanding, K | 126,313 | 124,922 | 119,952 | 114,760 | 114,588 |
Common Shares | 126 | 123 | 120 | 114 | 114 |
Retained earnings | -1,184,492 | -1,217,351 | -1,317,130 | -1,288,700 | -1,293,173 |
Other shareholders' equity | -4,163 | -2,266 | -1,528 | -713 | -1,126 |
TOTAL | $287,484 | $222,374 | $67,576 | $83,380 | $99,762 |
Total Liabilities And Equity | $1,008,975 | $1,039,246 | $919,711 | $647,909 | $490,119 |